Notably, CTSZ overexpression is linked to an immune-enriched yet immunosuppressive tumor microenvironment, characterized by increased infiltration of regulatory T cells and M2 macrophages, as well as upregulation of immune checkpoint molecules such as PD-1 and PD-L1. The gene discussed is CTSZ; the disease is neoplasm.